These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 27299728)

  • 1. Impact of MELD Allocation System on Waiting List and Early Post-Liver Transplant Mortality.
    Jurado-García J; Muñoz García-Borruel M; Rodríguez-Perálvarez ML; Ruíz-Cuesta P; Poyato-González A; Barrera-Baena P; Fraga-Rivas E; Costán-Rodero G; Briceño-Delgado J; Montero-Álvarez JL; de la Mata-García M
    PLoS One; 2016; 11(6):e0155822. PubMed ID: 27299728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A method for establishing allocation equity among patients with and without hepatocellular carcinoma on a common liver transplant waiting list.
    Vitale A; Volk ML; De Feo TM; Burra P; Frigo AC; Ramirez Morales R; De Carlis L; Belli L; Colledan M; Fagiuoli S; Rossi G; Andorno E; Baccarani U; Regalia E; Vivarelli M; Donataccio M; Cillo U;
    J Hepatol; 2014 Feb; 60(2):290-7. PubMed ID: 24161408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current allocation policy is favorable for patients with hepatocellular carcinoma waiting for liver transplantation.
    Ferre-Aracil C; Lledó JL; Aguilera L; Garcia-Paredes A; Rodríguez-Santiago E; Graus J; García-González M; Nuño J; López-Buenadicha A; López-Hervás P; Rodríguez-Gandía M; Gea F; Albillos A
    Dig Liver Dis; 2018 Dec; 50(12):1345-1350. PubMed ID: 29807872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of MELD score implementation on liver allocation: experience at a Brazilian center.
    da Silva Machado AG; de Medeiros Fleck A; Marroni C; Zanotelli ML; Cantisani G; de Mello Brandão AB
    Ann Hepatol; 2013; 12(3):440-7. PubMed ID: 23619261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MELD exceptions and new predictive score of death on long waiting lists for liver transplantation.
    Iacob S; Gheorghe L; Iacob R; Gheorghe C; Hrehoreţ D; Popescu I
    Chirurgia (Bucur); 2009; 104(3):267-73. PubMed ID: 19601457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Analysis of the organ allocation system for liver transplantation in Chile].
    Wolff R; Díaz LA; Norero B; Urzúa Á; Mezzano G; Humeres R; Innocenti F; Castro L; Pavez C; Derosas C; Elgueta S
    Rev Med Chil; 2020 Nov; 148(11):1541-1549. PubMed ID: 33844759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis C virus related cirrhosis decreased as indication to liver transplantation since the introduction of direct-acting antivirals: A single-center study.
    Ferrarese A; Germani G; Gambato M; Russo FP; Senzolo M; Zanetto A; Shalaby S; Cillo U; Zanus G; Angeli P; Burra P
    World J Gastroenterol; 2018 Oct; 24(38):4403-4411. PubMed ID: 30344424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective validation of a new priority allocation model for liver transplant candidates: an interim analysis.
    Vitale A; Saracino E; D'Amico FE; Grigoletto F; Burra P; Angeli P; Boccagni P; Brolese A; Zanus G; Neri D; Gringeri E; D'Amico F; Valmasoni M; Carraro A; Gambato M; Feltracco P; Romano A; Buggio M; D'Amico DF; Cillo U
    Transplant Proc; 2009 May; 41(4):1092-5. PubMed ID: 19460489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of the Liver Transplant Waiting List in Our Center.
    Emek E; Yesim Kara Z; Demircan FH; Serin A; Yazici P; Sahin T; Tokat Y; Bozkurt B
    Transplant Proc; 2019 Sep; 51(7):2413-2415. PubMed ID: 31474297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved waiting-list outcomes in Argentina after the adoption of a model for end-stage liver disease-based liver allocation policy.
    Cejas NG; Villamil FG; Lendoire JC; Tagliafichi V; Lopez A; Krogh DH; Soratti CA; Bisigniano L
    Liver Transpl; 2013 Jul; 19(7):711-20. PubMed ID: 23775946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes after combined liver-kidney transplant vs. kidney transplant followed by liver transplant.
    Chan EY; Bhattacharya R; Eswaran S; Hertl M; Shah N; Fayek S; Cohen EB; Hollinger EF; Olaitan O; Jensik SC; Perkins JD
    Clin Transplant; 2015 Jan; 29(1):60-6. PubMed ID: 25382251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prioritization for liver transplantation using the MELD score in Chile: Inequities generated by MELD exceptions.: A collaboration between the Chilean Liver Transplant Programs, the Public Health Institute and the National Transplant Coordinator.
    Díaz LA; Norero B; Lara B; Robles C; Elgueta S; Humeres R; Poniachik J; Silva G; Wolff R; Innocenti F; Rojas JL; Zapata R; Hunter B; Álvarez S; Cancino A; Ibarra J; Rius M; González S; Calabrán L; Pérez RM
    Ann Hepatol; 2019; 18(2):325-330. PubMed ID: 31010794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The association of pretransplant ferritin level with waiting list and post-transplant survival. Does ferritin actually predict outcome?
    Al-Freah MA; Kriese S; Foxton MR; Quaglia A; Bomford A; Heaton ND; O'Grady JG; Agarwal K; Wendon JA; Heneghan MA
    Transpl Int; 2013 Nov; 26(11):1070-9. PubMed ID: 24138201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cystatin C and Sarcopenia Predict Acute on Chronic Liver Failure Development and Mortality in Patients on the Liver Transplant Waiting List.
    Mauro E; Crespo G; Martinez-Garmendia A; Gutierrez-Acevedo MN; Diaz JM; Saidman J; Bermudez C; Ortiz-Patron J; Garcia-Olveira L; Zalazar F; Narvaez A; Spina JC; Orta R; Savluk L; Piano S; Marciano S; Gadano A
    Transplantation; 2020 Jul; 104(7):e188-e198. PubMed ID: 32150034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIGHER VALUES IN LIVER ELASTOGRAPHY AND MELD SCORE ARE MORTALITY PREDICTORS ON LIVER TRANSPLANT WAITING LIST.
    Nacif LS; Paranagua-Vezozzo DC; Matsuda A; Alves VAF; Carrilho FJ; Farias AQ; D'Albuquerque LC; Andraus W
    Arq Bras Cir Dig; 2018 Jun; 31(1):e1360. PubMed ID: 29947694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatic encephalopathy expands the predictivity of model for end-stage liver disease in liver transplant setting: Evidence by means of 2 independent cohorts.
    Lucidi C; Ginanni Corradini S; Abraldes JG; Merli M; Tandon P; Ferri F; Parlati L; Lattanzi B; Poli E; Di Gregorio V; Farcomeni A; Riggio O
    Liver Transpl; 2016 Oct; 22(10):1333-42. PubMed ID: 27434824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lower rates of receiving model for end-stage liver disease exception and longer time to transplant among nonalcoholic steatohepatitis hepatocellular carcinoma.
    Young K; Aguilar M; Gish R; Younossi Z; Saab S; Bhuket T; Liu B; Ahmed A; Wong RJ
    Liver Transpl; 2016 Oct; 22(10):1356-66. PubMed ID: 27348270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Model for end-stage liver disease-sodium and survival benefit in liver transplantation.
    Vitale A; Bertacco A; Gambato M; D'Amico F; Morales RR; Frigo AC; Zanus G; Burra P; Angeli P; Cillo U
    Transpl Int; 2013 Feb; 26(2):138-44. PubMed ID: 23194386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dropout rate from the liver transplant waiting list because of hepatocellular carcinoma progression in hepatitis C virus-infected patients treated with direct-acting antivirals.
    Zanetto A; Shalaby S; Vitale A; Mescoli C; Ferrarese A; Gambato M; Franceschet E; Germani G; Senzolo M; Romano A; Angeli P; Rugge M; Farinati F; Forton DM; Cillo U; Burra P; Russo FP
    Liver Transpl; 2017 Sep; 23(9):1103-1112. PubMed ID: 28544587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MELD EXCEPTION POINTS PROVIDE AN ENOURMOUS ADVANTAGE FOR RECEIVING A LIVER TRANSPLANT IN BRAZIL.
    Arruda S; Chedid MF; Jacinto MM; Álvares-DA-Silva MR
    Arq Gastroenterol; 2020; 57(3):254-261. PubMed ID: 32935744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.